Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by FewManChewon Aug 31, 2012 12:36pm

343 Views

Post# 20284677

Wha da fa?

Manipoolation? RCMP? What next? Simpo. Someone pay too much for stawk, or they simpee impatient. Get gwip, avidge down. Cancer not go away any time soon. It bigga then aids. It gonna kill 20% of popoolation accordian to currant stat. onc will reach sky. It may take fyve more ears, but it will.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features